Abstract
Chronic obstructive pulmonary disease (COPD) is associated with cerebrovascular abnormalities and an overproduction of reactive oxygen species. We hypothesised that COPD patients have oxidant-related cerebrovascular dysfunction. Our main objective was to evaluate cerebrovascular reactivity and its relationship with oxidative stress in females with COPD.
We studied eight females with moderate COPD and 10 healthy female control subjects of similar age. Transcranial Doppler ultrasound assessed cerebral blood flow (CBF) velocity during hypercapnia. Plasma was assessed at rest for DNA oxidation, advanced oxidation protein products, lipid peroxidation, nitrotyrosine, antioxidant enzyme activity (glutathione peroxidase and catalase) and end-products of nitric oxide metabolism.
Moderate COPD patients showed decreased cerebrovascular sensitivity to carbon dioxide (CO2) (COPD 1.17±0.54 versus control 2.15±0.73 cm·s−1·mmHg−1; p<0.01). COPD patients had higher levels of DNA and lipid oxidation, advanced oxidation protein products and higher glutathione peroxidase activity (p<0.05). Controlling for measures of oxidative stress (DNA and lipid oxidation, and advanced oxidation protein product) eliminates statistically significant differences between the COPD and control groups in the CBF sensitivity to CO2.
Females with moderate COPD were found to have cerebrovascular dysfunction. Our results suggest that increased levels of systemic oxidative stress may have implications in the cerebrovascular dysfunction observed during hypercapnia in COPD.
- Cerebrovascular circulation
- chronic obstructive pulmonary disease
- hypercapnia
- reactive oxygen species
- respiration
- transcranial Doppler ultrasonography
Footnotes
This article has supplementary material available from www.erj.ersjournals.com
Support Statement
Financial support was provided by the Hotchkiss Brain Institute (S.E. Hartmann, V. Pialoux and M.J. Poulin); Alberta Lung Association (S.E. Hartmann), University of Calgary (S.E. Hartmann), Alberta Heritage for Medical Research (R. Leigh and M.J. Poulin), Canadian Institutes of Health Research (M.J. Poulin) and The Calgary Foundation (S.E. Hartmann).
Statement of Interest
A statement of interest for R. Leigh can be found at www.erj.ersjournals.com/site/misc/statements.xhtml
- Received November 12, 2011.
- Accepted March 8, 2012.
- ©ERS 2012